CLOs on the Move

Frame.io

www.Frame.io

 
The world`s leading video review and collaboration platform. Built by real working video creators like you.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Caissa

Caissa, LLC is a software development firm founded by a group of senior professionals in the alternative investments industry. Caissa provides front office software solutions to allow institutions such as endowments, foundations, pension funds, family offices, and oCIOs to integrate a wide spectrum of investment-related analytics into a single web-based platform. The team at Caissa works closely with the institutional allocator community to ensure the technology platform offers the most relevant, flexible, state-of-the-art tools for multi-asset class allocators.

Curl Corporation

Curl Corporation is a Cambridge, MA-based company in the Software & Internet sector.

HCL Expense Management Services.

HCL Expense Management Services Inc.. is a Rutherford, NJ-based company in the Software & Internet sector.

Veeva

Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 450+ customers, ranging from the world`s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America.

InnovHeart

InnovHeart s.r.l., with operations in Colleretto Giacosa (Italy) and Poway (CA-USA), develops the Saturn System, a transcatheter mitral valve replacement (TMVR) platform intended to treat patients suffering from mitral valve disease. Saturn`s unique design allows the clinician to accurately deliver the prosthesis in the anatomically correct position, providing a stable and durable anchorage and sealing to the implant site. The system`s sub-annular ring affords inverse remodeling of the mitral annulus, and the low profile of the prosthesis ensures unimpeded flow from the left ventricle after implantation.